Atomera Incorporated (ATOM) | The Buildout — AI Infrastructure

Mkt cap · 52-wk · YTD · delayed
Updated Aug 12, 2026Q1 FY2026 reviewed
Atomera licenses Mears Silicon Technology, a thin film of reengineered silicon, to semiconductor manufacturers; its pipeline targets advanced logic, memory, power, and RF applications shaped by AI infrastructure demand.
GAA milestone cleared
One of two active GAA customers passed a manufacturability milestone.
GaN RF 1,000x better
Third-party RF data showed ~1,000x better linearity vs GaN-on-Si reference.
NAND doubles TAM
Management says NAND adoption would more than double MST TAM.
No production license
No royalty-bearing MST production agreement announced as of Q2 2026.
The Buildout Takeaway
Atomera is pre-revenue at scale but accumulating technical evidence across gate-all-around, memory, and GaN RF. The open question is whether any evaluation converts into a paid license; until then, the financials remain immaterial.
3 analysts·3 Buy0 Hold0 Sell
Coverage is thin — no price estimates on file, so no target is shown

2026 non-GAAP OpEx: approximately $18.5 million, narrowed to high end of $18.25–$18.75 million.
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

Atomera licenses Mears Silicon Technology, a thin film of reengineered silicon, to semiconductor manufacturers. The technology aims to improve performance and lower power consumption in advanced logic, memory, power, and RF devices. Those applications are being stressed by AI infrastructure demand for compute, memory bandwidth, and data-center efficiency, which is why the company's evaluation pipeline sits at the center of the AI buildout.

Market Cap
Revenue (TTM)$0M
Revenue Growth+0.0%
EBITDA Margin (TTM)-21600.0%
Net Cash$40M
Earnings Beats0 of 7
P/E (TTM)
EV/EBITDA (TTM)

What We Like

  • License terms are already on the table with a GAA customer that passed a manufacturability milestone; management says a fab install could happen late 2026 or a little beyond if results are good.
  • GaN-on-silicon RF data from third-party characterization partner Incize showed roughly 1,000x better linearity than a GaN-on-silicon reference, with improvement remaining 2–3 orders of magnitude across the measured power range.
  • Management says NAND adoption would more than double the TAM for MST; NAND manufactures more wafers per year than DRAM.
  • Cash and short-term investments were $41.1 million at Q1 2026 and $38.4 million at Q2 2026; the 10-Q states the company believes it has at least 24 months of capital.
  • Executive compensation alignment: $669,000 of 2025 bonus was withheld and tied to 2026 commercial objectives; first PSU tranche lapsed without vesting.

What We’re Watching

  • GAA electrical results from the current demonstration round—management says deposition takes 2–3 months, customer fab time several months; a 'good but not great' result could add roughly 9 months.
  • Q3 2026 non-GAAP OpEx: CFO said structural cost increases will flow through particularly next quarter; watch whether the implied H2 pace of about $8.85 million holds.
  • September 2026 IEEE presentation of the 4F2 DRAM TCAD study—a public milestone whose follow-up may indicate whether memory customers move beyond concept validation.
  • 2027 tool-lease renewal: a major tool lease at about $1.8 million per year is expected to rise 'pretty significantly,' with most impact in 2027.
Bottom Line

The thesis is strengthening on the technical evidence front but remains unproven commercially. GAA cleared a milestone, GaN RF produced third-party data, and NAND opened a new TAM, all in Q2; however, revenue is still negligible and no production license has been announced. The key open question is whether any evaluation converts into a paid license before the 2027 cost step-up pressures the runway.

Next upThe next dated catalyst is the September 2026 IEEE presentation of the 4F2 DRAM TCAD feasibility study, which will test whether memory customers move beyond concept validation. Beyond that, GAA electrical results from the current demonstration round could enable a late-2026 license/install if they land well.
Last Quarter — Q1 FY2026

Earnings

Q2 2026 revenue was $158,000, up from $11,000 in Q1 and above the $50,000–$100,000 guidance range. The revenue consisted primarily of wafer-delivery fees from one large IDM customer. Management highlighted that one of two active gate-all-around customers passed a significant manufacturability milestone. Gross margin for the latest quarter was not separately disclosed in the source material.

MetricQ1 FY2026Q4 FY2025Q1 FY2025YoY
Revenue$0M$0M$0M
Gross margin-1045.5%-162.0%100.0%-114550bps
EBITDA−$6M−$5M−$5M+23.5%
EPS$-0.17$-0.14$-0.17+0.4%
I'll spend real time on GaN, where I believe we may be witnessing the opening of a significantly new market for Atomera.— Scott Bibaud, President and CEO, 2026-08-04

Management tone: Management's tone shifted from Q1 confidence and detailed technical discussion to Q2 technical buoyancy on GaN and NAND, while adding more explicit timing caution on GAA. Management corrected an analyst's paraphrase of a GAA milestone, avoiding over-claiming, and voluntarily disclosed the PowerAmerica non-award.

Management Guidance

Management initiated Q2 2026 revenue guidance of $50,000 to $100,000 on the Q1 call; actual Q2 revenue of $158,000 exceeded that range. No Q3 2026 revenue guidance was provided. For full-year 2026 non-GAAP operating expense, management initially guided approximately $18.5 million, then narrowed expectation to the high end of a $18.25 million to $18.75 million range.

Business Trajectory

Trajectory

Revenue remains negligible but directionally up: $11,000 in Q1 2026 and $158,000 in Q2, driven by wafer-delivery fees from one large IDM. Q1 gross margin turned sharply negative because $126,000 of cost of revenue ran ahead of recognized revenue, a timing mismatch the company describes as advance labor and processing costs. Non-GAAP operating expenses rose from $4.8 million in Q1 to $5.1 million in Q2 on higher G&A, and the CFO said additional structural cost increases would flow through in Q3. Computed signals show revenue accelerating off a nearly zero base, with gross margin compressing and EBITDA margins expanding on a percentage basis because of small denominators.

Revenue & Margin Trajectory
RevenueGross margin$0$0$0$1$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$1M$0M$0M$0M$0M$0M$0M$0M$0M$0M0%-1046%Q2'16Q3Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26
RevenueGross margin$0$0$0$1$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$1M$0M$0M$0M$0M$0M$0M$0M$0M$0M0%-1046%Q2'16Q3Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26
Gross margin as reported.
Share Price — 12 Months
$5$10$052-wk high $12Aug '25NovFeb '26MayAug '26
52-week range $2–$12.
Share Price — 12 Months
$5$10$052-wk high $12Aug '25NovFeb '26MayAug '26
52-week range $2–$12.
The Numbers

The Model

The model projects FY+1 revenue of $0.31 million and EBITDA of negative $24 million, a negative 7,810% EBITDA margin. FY+2 revenue is projected at $3.0 million with EBITDA of negative $23 million, a negative 780% margin. The near-term is anchored by the current negligible revenue base and ongoing operating losses; FY+2 reflects the first meaningful step-up in revenue, though EBITDA remains deeply negative.

Revenue & EBITDA Projections
REVENUE$0M$0M$3MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN−$20M−$24M−$23M-780.0%FY25FY+1 (E)FY+2 (E)
REVENUE$0M$0M$3MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN−$20M−$24M−$23M-780.0%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$0M$0M$3M
YoY Growth+210.0%+867.7%
EBITDA−$20M−$24M−$23M
EBITDA Margin-20400.0%-7810.0%-780.0%

Projections are the median of 5 independent model runs.

Management initiated Q2 2026 revenue guidance of $50,000 to $100,000 on the Q1 call; actual Q2 revenue of $158,000 exceeded that range. No Q3 2026 revenue guidance was provided. For full-year 2026 non-GAAP operating expense, management initially guided approximately $18.5 million, then narrowed expectation to the high end of a $18.25 million to $18.75 million range.

What Could Go Right — and Wrong

What good looks like
  • A first GAA customer license and fab installation; license terms are already on the table, and management says it could happen late 2026 or a little beyond if results are good.
  • GaN RF evaluations convert to paid programs or a license; third-party data showed roughly 1,000x better linearity versus a GaN-on-silicon reference.
  • NAND supplier moves from interest to formal evaluation; management says NAND adoption would more than double the TAM for MST.
  • STMicroelectronics re-engagement becomes a disclosed product deal, reversing the October 2025 qualification pause.
  • September 2026 IEEE presentation of the 4F2 DRAM TCAD study generates visible customer follow-through.
What could go wrong
  • GAA electrical results are judged 'good, but not great,' triggering another demonstration round that management says could stretch timing by roughly 9 months.
  • GaN RF data fails to reproduce in customer designs; the current claim is company-reported through Incize with no customer-side confirmation yet.
  • NAND discussion, which is weeks old, never converts into a formal evaluation.
  • Cost trajectory worsens enough to shorten the 24-month liquidity runway stated in the Q1 10-Q.
  • Loss of a key engagement—the large IDM program, either GAA customer, or the second JDA partner—without a license.
What’s Next

Looking Ahead

The next twelve months turn on a small set of dated catalysts. In September 2026, Atomera presents its 4F2 DRAM TCAD feasibility study at an IEEE conference. In Q3 2026, the CFO said some structural cost increases from service providers will flow through the P&L. A possible GAA customer license and fab installation could occur late 2026 or a little beyond if electrical results are good; otherwise a further demonstration round may add roughly nine months. The major tool-lease step-up is expected to have most of its impact in 2027, not the second half of 2026.

Catalysts
  • September 2026IEEE 4F2 DRAM TCAD presentation — Public milestone; tests whether memory customers move beyond concept validation.
  • Q3 2026Structural cost increases hit P&L — CFO said some service-provider cost increases flow through next quarter.
  • Late 2026 or a little beyondPossible GAA license/install — Depends on current demonstration round electrical results.
  • 2027Major tool-lease step-up — Negotiated lease renewal expected to rise 'pretty significantly'.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$0M$0M$0M+0.0%
Gross Margin11.0%-375.2%-162.0%38,615bps
EBITDA−$18M−$20M−$159M-12.1%
EBITDA Margin-18200.0%-20400.0%-21600.0%220,000bps
Net Income−$18M−$20M−$21M-9.2%
Free Cash Flow−$13M−$15M−$119M
Net Cash

Key Ratios (Trailing)

Valuation
  • P/E TTM
  • EV/EBITDA TTM
  • EV/Revenue TTM
  • Price/FCF TTM
Profitability
  • Gross Margin (TTM)-162.0%
  • EBITDA Margin (TTM)-21600.0%
  • Net Margin (TTM)-21100.0%
  • ROIC-2482.9%
  • SBC / Revenue5300.0%
Reference

The Company

Atomera licenses Mears Silicon Technology, or MST, described in its 10-K as a thin film of reengineered silicon. It does not design or manufacture wafers or integrated circuits. Instead, it develops and licenses proprietary processes and technologies for the $700+ billion semiconductor industry, targeting greater performance and lower power consumption. Its disclosed products are MST, MST-SP for 3–5 volt power devices, MST-SPX for power devices up to 48V, and MSTcad simulation software that models MST effects inside Synopsys TCAD.

The company operates as a single operating segment with a small physical footprint: an executive office in Los Gatos, California of 4,101 square feet leased to March 31, 2031, and an office and cleanroom in Tempe, Arizona. It runs two leased epitaxial reactors—an Applied Materials Centura reactor handling 200mm and 300mm wafers, and a 200mm ASM Epsilon reactor leased from Lawrence Semiconductor. The 10-K warns that epi-tool downtime could delay or prevent customer licenses.

Business Segments

MST
Core reengineered-silicon thin-film technology
The foundational technology positioned for advanced logic, memory, power, and RF applications.
Growth driver: AI-driven demand across GAA, DRAM/NAND, GaN, and power.
MST-SP / MST-SPX
Power devices from 3–5 volts up to 48V
Power device technology aimed at AI data-center efficiency and high-frequency demands.
Growth driver: TrenchFET and HBT development for AI data centers.
MSTcad
Simulation software integrated with Synopsys TCAD
Models MST effects in TCAD; collaboration expanded into GaN workflows.
Growth driver: Sync with Synopsys to accelerate customer design cycles.

Competitive Landscape

Atomera does not name a direct technology competitor for MST in its public filings. Applied Materials appears in the source material as a tool lessor and adjacent equipment supplier; a neighbor transcript read-through notes its GAA transition drove record foundry revenue and record ALD/epitaxy revenue. No reviewed source states whether Applied Materials competes directly with MST.

  • Applied Materials
    Documented tool lessor and adjacent equipment supplier. A neighbor transcript read-through notes its GAA transition drove record foundry revenue and record ALD/epitaxy revenue; no direct MST competition is confirmed.
Applied Materials is discussed as an adjacent equipment supplier rather than a confirmed MST competitor; no direct competitor is named in the sources.

Supply Chain

Atomera sits upstream of chip manufacturing as a technology licensor, not a fabricator. Its chain runs from epi-tool lessors and TCAD partners to semiconductor manufacturers. No reviewed neighbor transcript mentioned Atomera by name.

Supplier
Applied Materials
Leases Atomera a Centura reactor for 200mm/300mm wafers.
Supplier
Lawrence Semiconductor
Leases Atomera a 200mm ASM Epsilon reactor.
Supplier
Synopsys
Supplies TCAD simulation platform; collaboration since 2017.
Supplier
Incize
Third-party characterization partner that delivered GaN RF data.
MST precise doping-profile control.
ATOM
Develops and licenses MST thin film of reengineered silicon using two leased epi reactors.
Installed MST film recipe under April 2023 license; qualification paused October 2025.
Asahi Kasei Microdevices (AKM)
Integration license agreement.
Unnamed large IDM customer
Paying wafer-delivery fees; primary Q1/Q2 revenue source.
Unnamed first JDA customer
Leading semiconductor provider; installed MST recipe; Phase Four.
Unnamed second JDA customer
Major semiconductor foundry; active RF-SOI wafer runs.

Analysis updated Aug 12, 2026, reviewing Q1 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on ATOM: Earnings recap